跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Appemin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Appemin
Approved
STANDARD
Appemin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e1a32465fae29361
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
e1a32465fae29361
Drug Approval Philippines Name
Appemin
Product Name
Appemin
Registration Number
DRP-7742-06
Brand Name
Appemin
Generic Name
Multivitamins + Minerals + Buclizine
Dosage Form
Syrup
Dosage Strength
Formulation: Each 5 ml (1 teaspoonful) contains: L-Lysine Hydrochloride Cyanocobalamin (Vitamin B12) Thiamine Hydrochloride (Vitamin B1) Pyridoxine Hydrochloride (Vitamin B6)I 125 mg 10 mg Iron (equivalent to 27.78 mg Iron (III) Hydroxude Polymaltose) Buclizine Hydrochloride
Manufacturer
Lloyd Laboratories, Inc.
Trader
Westfield Pharmaceuticals, Inc.
Distributor
Medirich Pharma Distributor Corp.
Issuance Date
28 May 2024
Expiry Date
05 September 2029
Pharmacologic Category
Vitamins/Appetite Stimulant
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e1a32465fae29361
Type
Standard
Back to Philippines FDA Approvals